The clinical trial of leuprorelin acetate suggests that androgen deprivation inhibits the nuclear accumulation and/or stabilization of mutant AR in the motor neurons, and thereby stabilizes the disease progression in SBMA patients. This evidence concerns the gene AR and Kennedy disease.